Citation: | WANG Yiting, ZHAO Mengge, SHENG Xueping, ZHANG Jian, JIANG Cuihua, YIN Zhiqi. Effect of triterpenic acid-enriched fraction from Cyclocarya paliurus on high glucose-induced pancreatic α cells insulin resistance[J]. Journal of China Pharmaceutical University, 2018, 49(2): 215-221. DOI: 10.11665/j.issn.1000-5048.20180212 |
[1] |
Heller A,Feldman B.Electrochemistry in diabetes management[J].Account Chem Res,2010,43(7):963-973.
|
[2] |
Organization WH.Global report on diabetes[J].Working Papers,2016.
|
[3] |
Unger R,Orci L.The essential role of glucagon in the pathogenesis of diabetes mellitus[J].Lancet,1975,1(7897):14-16.
|
[4] |
Gosmain Y,Masson MH,Philippe J.Glucagon:the renewal of an old hormone in the pathophysiology of diabetes[J].J Diabetes,2013,5(2):102-109.
|
[5] |
Unger RH, Cherrington AD. Glucagonocentric restructuring of diabetes:a pathophysiologic and therapeutic makeover[J].J Clin Invest,2012,122(1):4-12.
|
[6] |
Tsuchiyama N,Takamura T,Ando H,et al.Possible role of alpha-cell insulin resistance in exaggerated glucagon responses to arginine in type 2 diabetes[J].Diabetes Care,2007,30(30):2583-2587.
|
[7] |
Hong J,Jeppesen PB,Hermansen K.Effects of elevated fatty acid and glucose concentrations on pancreatic islet function in vitro[J].Diabetes Obes Metab,2010,11(4):397-404.
|
[8] |
Wang QQ,Jiang CH,Fang SZ,et al.Antihyperglycemic,antihyperlipidemic and antioxidant effects of ethanol and aqueous extracts of Cyclocarya paliurus leaves in type 2 diabetic rats[J].J Ethnopharmacol,2013,150(3):1119-1127.
|
[9] |
Fan BD,Wei Y,Li CH,et al.Research progress in chemical constituents and hpyerglycemic activity of Cyclocarya paliurus[J].Chin J Exp Tradit Med Form(中国实验方剂学杂志),2014,20(13):239-242.
|
[10] |
Kurihara H,Fukami H,Kusumoto A,et al.Hypoglycemic action of Cyclocarya paliurus(Batal.)Iljinskaja in normal and diabetic mice[J].J Agric Chem Soc Japan,2003,67(4):877-880.
|
[11] |
Li TT,Wu CY,Fang SZ,et al.Content stability and hypoglycemic effect of Cyclocarya paliurus capsule[J].Sci Technol Food Ind(食品工业科技),2013,34(19):337-340.
|
[12] |
Xu G,Yoshitomi H,Wen S,et al.Cyclocarya paliurus(Batal.)Ijinskaja aqueous extract(CPAE)ameliorates obesity by improving insulin signaling in the hypothalamus of a metabolic syndrome rat model[J].Evid-Based Compl Alt,2017,2017(2):4602153.
|
[13] |
Zhu KN,Jiang CH,Tian YS,et al.Two triterpeniods from Cyclocarya paliurus(Batal)Iljinsk(Juglandaceae)promote glucose uptake in 3T3-L1 adipocytes:the relationship to AMPK activation[J].Phytomedicine,2015,22(9):837-846.
|
[14] |
Shen XX,Li HL,Pan L,et al.Glucotoxicity and cell dysfunction:involvement of the PI3K/Akt pathway in glucose-induced insulin resistance in rat islets and clonal TC1-6 cells[J].Endocr Res,2012,37(1):12-24.
|
[15] |
Godsland IF, Walton C, Wynn V. Role of glucose and insulin resistance in development of type 2 diabetes mellitus[J].Lancet,1992,340(8831):1347-1348.
|
[16] |
Kisanuki K,Kishikawa H,Araki E,et al.Expression of insulin receptor on clonal pancreatic alpha cells and its possible role for insulin-stimulated negative regulation of glucagon secretion[J].Diabetologia,1995,38(4):422-429.
|
[17] |
Mizusawa N,Hasegawa T,Ohigashi I,et al.Differentiation phenotypes of pancreatic islet beta- and alpha-cells are closely related with homeotic genes and a group of differentially expressed genes[J].Gene,2004,331(1):53-63.
|
[18] |
Piro S,Maniscalchi ET,Monello A,et al.Palmitate affects insulin receptor phosphorylation and intracellular insulin signal in a pancreatic alpha-cell line[J].Endocrinology,2010,151(9):4197-4206.
|
[19] |
Chen X,Hermansen K,Xiao J,et al.Isosteviol has beneficial effects on palmitate-induced α-cell dysfunction and gene expression[J].PLoS One,2012,7(3):e34361.
|
[20] |
Mcgirr R,Ejbick CE,Carter DE,et al.Glucose dependence of the regulated secretory pathway in alphaTC1-6 cells[J].Endocrinology,2005,146(10):4514-4523.
|
[21] |
Unger RH.The banting memorial lecture 1975.Diabetes and the alpha cell[J].Diabetes,1976,25(2):136-151.
|
[22] |
Umpaichitra V,Bastian W,Taha D,et al.C-peptide and glucagon profiles in minority children with type 2 diabetes mellitus[J].J Clin Endocr Metab,2001,86(4):1605-1609.
|
[23] |
Ferrannini E,Muscelli E,Natali A,et al.Association of fasting glucagon and proinsulin concentrations with insulin resistance[J].Diabetologia,2007,50(11):2342-2347.
|
[24] |
Diao JY,Asghar Z,Chan CB.Glucose-regulated glucagon secretion requires insulin receptor expression in pancreatic α-cells[J].J Biol Chem,2005,280(39):487-496.
|
[25] |
Kaneko K,Shirotani T,Araki E,et al.Insulin inhibits glucagon secretion by the activation of PI3-kinase in In-R1-G9 cells[J].Diabetes Res Clin Pr,1999,44(2):83-92.
|
[1] | CHEN Xi, JIN Liang. Research progress on sumoylation in type 2 diabetes mellitus[J]. Journal of China Pharmaceutical University, 2025, 56(1): 125-131. DOI: 10.11665/j.issn.1000-5048.2023112002 |
[2] | MU Jinming, LIU Yue, ZHANG Fangfang, JIN Liang. Relationship between circular RNA and type 2 diabetes and its clinical application[J]. Journal of China Pharmaceutical University, 2020, 51(3): 374-378. DOI: 10.11665/j.issn.1000-5048.20200316 |
[3] | LI Yongrong, CHENG Tao, WANG Yongsheng, LI Qin, GAO Bo, HE Yun, BAI Yu. Effect of extract of selenium-enriched Astragalus membranaceus on insulin resistance in streptozotocin-induced diabetic rats[J]. Journal of China Pharmaceutical University, 2018, 49(6): 739-745. DOI: 10.11665/j.issn.1000-5048.20180616 |
[4] | DU Te, CHEN Jing, SHEN Xu. Research advances in susceptibility genes of non-alcoholic fatty liver disease and its association with type 2 diabetes[J]. Journal of China Pharmaceutical University, 2018, 49(5): 537-544. DOI: 10.11665/j.issn.1000-5048.20180504 |
[5] | CAO Lanjie, ZHU Kuiniu, JIANG Cuihua, GUNN ·Jordan, CHE Chun-Tao, ZHANG Jian, YIN Zhiqi. Intervention effects of the extract of Alismatis Rhizoma on streptozotocin-induced type 2 diabetic rats[J]. Journal of China Pharmaceutical University, 2017, 48(5): 601-608. DOI: 10.11665/j.issn.1000-5048.20170516 |
[6] | WANG Xinning, XU Bin, ZHOU Jinpei, ZHANG Huibin. Advances of anti-diabetic drugs based on new targets[J]. Journal of China Pharmaceutical University, 2015, 46(2): 141-152. DOI: 10.11665/j.issn.1000-5048.20150202 |
[7] | LI Chen, YUAN Linhua, MA Xueqin, LIU Xiaoquan, XI Tao. Variation of cardiovascular risk biomarkers in type 2 diabetes mellitus[J]. Journal of China Pharmaceutical University, 2013, 44(3): 257-262. DOI: 10.11665/j.issn.1000-5048.20130314 |
[8] | HE Bi-xia, QIAO Li-yun, PENG Jun, XIE Zhi-ping, DING Qi-long. Effects and mechanisms of mifepristone on insulin-resistant HepG 2 cells[J]. Journal of China Pharmaceutical University, 2011, 42(2): 153-159. |
[9] | Influences on Serum Insulin and Glucose by Different Fasting Time in Alloxan Diabetic Mice[J]. Journal of China Pharmaceutical University, 2001, (3): 59-62. |
[10] | Determination of the Concentration of Intracellular Calcium in Lymphocyte by Fluo 3 AM and Study of the Influence of the Drugs on Calcium Release[J]. Journal of China Pharmaceutical University, 1999, (6): 53-57. |